Vol 2, No 2 (2017)
Case report
Published online: 2017-06-28

open access

Page views 649
Article views/downloads 1284
Get Citation

Connect on Social Media

Connect on Social Media

Intravitreal anti-VEGF therapy in macular oedema secondary to racemose haemangiomatosis of the retina

Magdalena Tylus1, Jerzy Mackiewicz1, Joanna Dolar-Szczasny1, Anna Święch-Zubilewicz1
Ophthalmol J 2017;2(2):58-60.

Abstract

Racemose haemangiomatosis of the retina is a sporadic, mostly unilateral, congenital arteriovenous malformation (AVM), comprising abnormal junctions between arteries and veins that omit capillaries. Typically, vascular malformations are asymptomatic and incidentally discovered. Advanced changes may be related to the presence of subretinal fluid and exudates, even though these lesions are classified as benign. Many complications can lead to severe or permanent visual impairment. Direct methods of treatment of primary retinal vascular anomalies have not been developed yet. The aim of this case report is to present the anti-VEGF therapy in the treatment macular oedema secondary to racemose haemangioma.

References

  1. Turell ME, Singh AD. Vascular tumors of the retina and choroid: diagnosis and treatment. Middle East Afr J Ophthalmol. 2010; 17(3): 191–200.
  2. Knutsson KA, De Benedetto U, Querques G, et al. Primitive retinal vascular abnormalities: tumors and telangiectasias. Ophthalmologica. 2012; 228(2): 67–77.
  3. Wyburn-Mason R. Arteriovenous aneurysm of midbrain and retina, facial, nevi and mental changes. Brain. 1943; 66(3): 163–203.
  4. Théron J, Newton TH, Hoyt WF. Unilateral retinocephalic vascular malformations. Neuroradiology. 1974; 7(4): 185–196.
  5. Szaflik J, Starzycka M. Patologia narządu wzroku i guzy wewnątrzgałkowe. Seria Basic and Clinical Science Course (BCSC 4). Urban&Partner, Wrocław 2003: 263.
  6. Archer DB, Deutman A, Ernest JT, et al. Arteriovenous communications of the retina. Am J Ophthalmol. 1973; 75(2): 224–241.
  7. Heimann H, Jmor F, Damato B. Imaging of retinal and choroidal vascular tumours. Eye (Lond). 2013; 27(2): 208–216.
  8. Kenawy N, Groenwald C, Damato B. Treatment of a vasoproliferative tumour with intravitreal bevacizumab (Avastin). Eye (Lond). 2007; 21(6): 893–894.
  9. Shah GK, Shields JA, Lanning RC. Branch retinal vein obstruction secondary to retinal arteriovenous communication. Am J Ophthalmol. 1998; 126(3): 446–448.
  10. Qin Xj, Huang C, Lai K. Retinal vein occlusion in retinal racemose hemangioma: a case report and literature review of ocular complications in this rare retinal vascular disorder. BMC Ophthalmol. 2014; 14: 101.
  11. Panagiotidis D, Karagiannis D, Tsoumpris I. Spontaneous development of macular ischemia in a case of racemose hemangioma. Clin Ophthalmol. 2011; 5: 931–932.
  12. Effron L, Zakov ZN, Tomsak RL. Neovascular glaucoma as a complication of the Wyburn-Mason syndrome. J Clin Neuroophthalmol. 1985; 5(2): 95–98.
  13. Sanfilippo CJ, Sarraf D. Congenital macrovessel associated with cystoid macular edema and an ipsilateral intracranial venous malformation. Retin Cases Brief Rep. 2015; 9(4): 357–359.
  14. Onder HI, Alisan S, Tunc M. Serous retinal detachment and cystoid macular edema in a patient with Wyburn-Mason syndrome. Semin Ophthalmol. 2015; 30(2): 154–156.
  15. Soliman W, Haamann P, Larsen M. Exudation, response to photocoagulation and spontaneous remission in a case of bilateral racemose haemangioma. Acta Ophthalmol Scand. 2006; 84(3): 429–431.
  16. Winter E, Elsås T, Austeng D. Anti-VEGF treating macular oedema caused by retinal arteriovenous malformation - a case report. Acta Ophthalmol. 2014; 92(2): 192–193.